• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25RWC W/ RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25RWC W/ RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX25RWC
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/12/2020
Event Type  malfunction  
Manufacturer Narrative
Terumo has received the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
 
Event Description
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, some dark colored spots appeared attached on the inner surface of the oxygenator chamber.Per user facility the act was normal during all case never below 400.Even after many black spots observed in the oxygenator the pressure drop never increased and oxygenation was very good.No known impact or consequence to patient.Product was not changed out.Procedure was completed successfully.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on april 1, 2020.Upon further investigation of the reported event, the following information is new and/or changed: h6 (identification of evaluation codes 10, 11, 3331, 213, 67).Method code #1: 10 - testing of actual/suspected device.Method code #2: 11 - testing of device from same lot/batch retained by manufacturer.Method code #3: 3331 - analysis of production records.Results code: 213 - no device problem found.Conclusions code: 67 - no problem detected.The actual sample was returned for investigation and photos taken upon receipt showed that a blood clot had been formed.However, it was not determined when the clot formed.The sample, after having been rinsed and dried was tested for its gas transfer performance and no anomalies were revealed with the obtained values meeting the factory specifications.Subsequently, bovine blood was circulated in the circuit while the pressure drop was determined.The obtained values were confirmed to meet the factory's specifications and no obstruction was confirmed.During the blood circulation, the appearance of dark colored spots inside the oxygenator as indicated in the complaint was not reproduced.A physiological saline solution was then flowed into the blood channel and no formation of blood clots were visually observed.Device history record and incoming inspection record from the involved product/lot number combination were reviewed and confirmed with no anomaly.The investigation results verified that the actual sample, after having been rinsed, was the normal product with no issue in the gas transfer performance and the pressure drop.All available information has been placed on file in quality management for appropriate tracking, trending and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERILE FX25RWC W/ RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
MDR Report Key9912112
MDR Text Key200832208
Report Number1124841-2020-00081
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier00699753450837
UDI-Public(01)00699753450837
Combination Product (y/n)N
PMA/PMN Number
K151791
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/01/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2022
Device Model Number3CX*FX25RWC
Device Catalogue NumberN/A
Device Lot NumberXL09
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/25/2020
Was the Report Sent to FDA? No
Date Manufacturer Received05/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-